X0303 4 2011-05-18 0000850693 ALLERGAN INC AGN 0001298941 Whitcup Scott M 2525 DUPONT DRIVE IRVINE CA 92612 1 Executive VP, R&D, CSO Common Stock 2011-05-18 4 M 0 5500 28.92 A 29450 D Common Stock 2011-05-18 4 S 0 5500 83.8909 D 23950 D Common Stock 1696.1074 I By 401(k) Common Stock 1739.0735 I By Esop Employee Stock Option (Right to Buy) 28.92 2011-05-18 4 M 0 5500 0 D 2013-01-06 Common Stock 5500 0 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 5, 2010. Includes shares acquired under the Allergan, Inc. Dividend Reinvestment Plan. Shares allocated to reporting person's SIP account as of reporting date. Shares allocated to the reporting person's ESOP account as of reporting date. The option becomes exercisable in four equal annual installments beginning January 7, 2004. /s/ Matthew J. Maletta, attorney-in-fact for Scott M. Whitcup 2011-05-18